Immunoprecise Antibodies Ltd
IPA2.070USD
0.000
Close 12/19, 16:00（ET）Quotes delayed by 15 min
95.54MMarket Cap
LossP/E TTM
Immunoprecise Antibodies Ltd Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
17.81M
0.60%
EPS(YoY)
-0.66
14.71%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its total revenue reached 17.81M, with a year-on-year change of 0.60%.
What is the Earnings Per Share (EPS) of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its Earnings Per Share (EPS) was -0.656, with a year-on-year change of 14.71%.
What is the net income of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its net income was -21.96M, with a year-on-year change of -11.90%.
What is the net margin of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its net profit margin was -123.30%, with a year-on-year change of -11.24%.
What is the gross margin of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its gross margin was 47.31%, with a year-on-year change of 27.67%.
What is the debt-to-asset ratio of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its debt-to-asset ratio was 30.16%, with a year-on-year change of 32.24%.
What is the Return on Equity (ROE) of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its Return on Equity (ROE) was -105.08%, with a year-on-year change of -77.32%.
What is the Return on Assets (ROA) of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its Return on Assets (ROA) was -57.90%, with a year-on-year change of -46.80%.
What is the operating profit of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its operating profit was -8.99M, with a year-on-year change of 9.54%.
What are the current assets of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its current assets were 13.62M, with a year-on-year change of 18.56%.
What are the total assets of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its total assets of Immunoprecise Antibodies Ltd were 32.27M, with a year-on-year change of -46.20%.
What are the total liabilities of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its total liabilities of Immunoprecise Antibodies Ltd were 15.12M, with a year-on-year change of -42.01%.
What is the total equity of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its total equity of Immunoprecise Antibodies Ltd was 17.16M, with a year-on-year change of -49.42%.
What is the net operating income of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its net operating income of Immunoprecise Antibodies Ltd was -21.96M, with a year-on-year change of -11.90%.
What is the net investment of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its net investment of Immunoprecise Antibodies Ltd was -580.25K, with a year-on-year change of 48.58%.
What is the net financing of Immunoprecise Antibodies Ltd?
According to Immunoprecise Antibodies Ltd's FY2025 earnings report, its net financing of Immunoprecise Antibodies Ltd was 10.82M, with a year-on-year change of 1367.25%.
